SOLICITATION NOTICE
A -- Development and Validation of mutiplex assay for identifying and differentiating serotypes of botulinum nerotoxins (BoNT)
- Notice Date
- 3/14/2014
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Office of the Chief Procurement Officer, Washington, District of Columbia, 20528, United States
- ZIP Code
- 20528
- Solicitation Number
- JA08414
- Point of Contact
- Michael E. Jones, Phone: 202-254-5676, Danette Williams, Phone: 2022545891
- E-Mail Address
-
michael.e.jones@dhs.gov, danette.williams@hq.dhs.gov
(michael.e.jones@dhs.gov, danette.williams@hq.dhs.gov)
- Small Business Set-Aside
- N/A
- Description
- The DHS Directorate of Science and Technology, Chemical and Biological Defense Division (CBD) proposes to enter into a sole source award to Radix Biosolutions Ltd., 111 W. Cooperative Way, Suite 120, Georgetown, Texas for purposes of completing the development and validation of a multiplex assay for identifying and differentiating each of the 7 serotypes of botulinum neurotoxins (BoNT). Within the DHS Surveillance and Detection R&D Program, the BioAssays Project fosters the development of assays to improve the ability to identify and characterize biothreat agents. The goal is to develop highly reliable assays for selected biothreat agents to provide DHS S&T management with high confidence assay results. The work to be performed under this proposed action will be the completion and validation of the BoNT assays, and development of an SEB multiplex assay for several serotypes of Staphylococcal endotoxins (A, B, C, D, etc.). The completed platform of assays will be ideal for distributed identification of toxin antigens, and the first assay developed has already been demonstrated as the most specific and sensitive assay for ricin available. The proposed contractor has filed patents on the methods, algorithms, and reagents, and is currently working on validation of a similar assay for all seven Botulinum neurotoxin serotypes which has been under development for two years. Note 22: This pre-award synopsis is for informational purposes only. Technical proposals will not be considered, however technical capability statements may be submitted, only if your organization has the technical capabilities necessary to meet the above stated needs. If such documents are submitted, they may be reviewed for consideration to open this requirement up for competition. The determination to open up the requirement to competition is at the sole discretion of the Government. All submissions become the property of the Federal Government, and will not be returned.  
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DHS/OCPO/DHS-OCPO/JA08414/listing.html)
- Place of Performance
- Address: 111 W. Cooperative Way, Suite 120, Georgetown, Texas, 78628, United States
- Zip Code: 78628
- Zip Code: 78628
- Record
- SN03311467-W 20140316/140314234803-28facce5ea6b091bd15ba660d8cb0af6 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |